In 2019, Allianz organised the Reimagine Your Medical Choices Forum, focused on addressing viable options in treatment, protection and care available when facing cancer. One of the protection solutions shared by Allianz Malaysia is MediSafe Infinite+.
MediSafe Infinite+ is a comprehensive medical rider of Allianz PowerLink that offers extensive cancer coverage which allows customers to gain access to new medical technology in cancer treatment such as genomic testing, targeted therapy, hormonal therapy and immunotherapy. In addition to that, there is access to Global Expert Medical Opinion (GEMO) as well as high overall annual limit and no overall lifetime limit. The coverage is available across seven plans ranging from Plan 150 (overall Annual Limit of RM850,000) to Plan 500 (overall Annual Limit of RM2,500,000).